Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 1, 2006, Pages 105-109

  El Miedany, Yasser ^a,d   Youssef, Sally ^a   Ahmed, Ihab ^b,c   El Gaafary, Maha ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c Saudi German Hospital   (Saudi Arabia)

^d AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CELECOXIB; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETORICOXIB; IBUPROFEN; IPRATROPIUM BROMIDE; KETOPROFEN; MELOXICAM; MONTELUKAST; NAPROXEN; NEDOCROMIL SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; ROFECOXIB; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; ZAFIRLUKAST;

ADULT; AIRWAY OBSTRUCTION; ARTHRALGIA; ARTHRITIS; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DELAYED HYPERSENSITIVITY; DISEASE EXACERBATION; DRUG SAFETY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; INFLAMMATION; LARYNX EDEMA; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RHEUMATIC DISEASE; SINGLE BLIND PROCEDURE; SPIROMETRY; TENDINITIS; UNSPECIFIED SIDE EFFECT;

EID: 33746588590     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61378-6     Document Type: Article

References (25)

1. Namazy JA, Simon RA. Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2002;89:542-550.
2. Giraldo B, Blumenthal MN, Spink WW. Aspirin intolerance and asthma: a clinical and immunological study. Ann Intern Med. 1969;71:479-496.
3. McDonald JR, Mathison DA, Stevenson DD. Aspirin intolerance in asthma detection by oral challenge. J Allergy Clin Immunol. 1972;50:198-207.
4. Szczeklik A, Niz Ankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax. 2000;55(suppl 2):S42-S44.
5. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseeca F. NSAID hypersensitivity in the cox-2 inhibitor era. ACR Int. 2001;13:211-218.
6. Babu KS, Salvi SS. Aspirin and asthma. Chest. 2000;118:1470-1476.
7. Szczeklik A, Niz Ankowska E, Mastalerz L, Szabo Z. Analgesics and asthma. Am J Ther. 2002;9:233-243.
8. Stevenson DD, Simon RA, Christiansen SC. Lack of cross reactivity between selective cox-2 inhibitors and aspirin in ASA sensitive asthmatics [abstract]. J Allergy Clin Immunol. 2000;105:5273.
9. Yoshida S, Ishizaki Y, Onuma K, Shoji T, Nakagawa H, Amayasu H. Selective cyclo-oxygenase 2 inhibitor in patients with aspirin induced asthma [letter]. J Allergy Clin Imunol. 2000;106:1201-1202.
10. Dahlen B, Szczeklik A, Murray JJ. Celecoxib in patients with asthma and aspirin intolerance [letter]. N Engl J Med. 2000;344:142.
11. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive patients with asthma. J Allergy Clin Immunol. 2001;108:47-51.
12. Szczeklik A, Niz Ankowska E, Bochnenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific cox-2 inhibitor in aspirin induced asthma. Clin Exp Allergy. 2001;31:219-225.
13. Merck Sharp & Dohme. Arcoxia: Summary of Product Characteristics. Merck Sharp & Dohme. Data on file.
14. Pauls JD, Simon RA, Daffern P, Stevenson DD. Effectiveness of the 5-LO inhibitor zileuton during oral challenges in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol. 2000;85:40-45.
15. Szczeklik A, Stevenson DD. Aspirin induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999;104:5-13.
16. Sampson AP. Drug induced asthma: NSAIDs, β-blockers and ACE inhibitors. In: Holgate ST, Boushey HA, Fabbri LM, eds. Difficult Asthma. London, England: Martin Dunitz; 1999:127-146.
17. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ. 1975;1:67-69.
18. Settipane RA, Stevenson DD. Cross senility with acetaminophen in aspirin sensitive subjects with asthma. J Allergy Clin Immunol. 1989;84:26-33.
19. Bianco S, Robuschi M, Petrigni G. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs. 1993;46:115-120.
20. Kosnik M, Music E, Matjaz F. Relative safety of meloxicam in NSAID intolerant patients. Allergy. 1998;53:1231-1233.
21. Andri L, Senna G, Betteli C, Giovanni S, Scaricabarozzi I, Mezzelani P. Tolerability of nimesulide in aspirin sensitive patients. Ann Allergy. 1994;72:29-32.
22. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T. Safety of cox-2 inhibitor in patients with aspirin sensitive asthma. Chest. 2002;121:1812-1817.
23. Woessner KM, Simon RA, Stevenson DD. The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum. 2002;46:2201-2206.
24. Niz Ankowska E, Szczeklik A. Glucocorticoids attenuate aspirin precipitated adverse reactions in aspirin intolerant patients with asthma. Am Allergy. 1989;63:159-162.
25. Stevenson DD, Simon Ra, Mathison DA, Christiansen SC. Montelukast is only partially effective in inhibiting aspirin responses in aspirin sensitive asthmatics. Ann Allergy Asthma Immunol. 2000;85:477-482.